• Je něco špatně v tomto záznamu ?

Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients

M. Švajdler, R. Mezencev, J. Kašpírková, D. Kacerovská, DV. Kazakov, O. Ondič, M. Michal,

. 2016 ; 38 (10) : 751-7.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014083

An increased rate of second nonmelanoma skin cancers is found in immunocompromised patients. Epidemiological and molecular data implicate ultraviolet radiation as the major risk factor. In addition, there is increasing evidence supporting the role of human papillomavirus (HPV) in the pathogenesis of premalignant and malignant skin lesions in both immunocompetent and immunocompromised patients. In a retrospective cross-sectional study, the authors examined the expression of p16 by immunohistochemistry and the presence of mucosal (α-genus) and cutaneous/epidermodysplasia verruciformis (β-genus) HPV DNA by polymerase chain reaction in 29 biopsy specimens of extragenital/extraungual Bowen disease (BD) from 24 Eastern European white immunocompromised patients. Furthermore, the author evaluated the association between the expression of p16 protein and the presence of HPV DNA. Among 25 specimens from 21 patients evaluable by polymerase chain reaction, HPV DNA was detected in 10 (40%) BD lesions from 9 patients. Beta-HPV predominated over alpha-HPV types. Among 29 immunohistochemically evaluable BD specimens, 22 lesions (∼76%) from 20 patients were scored as p16 positive. HPV DNA-positive and HPV DNA-negative lesions displayed the same proportion of p16 positivity (80%) and no correlation was found between the HPV DNA presence and the p16 expression status. Our pilot study demonstrated that β-HPV infections predominate in BD cases diagnosed among immunocompromised patients, although high- and low-risk mucosal (alpha) HPV genotypes may be detected in a minority of cases. In contrast to anogenital HPV-associated lesions, positive p16 expression is not a reliable marker of high-risk α-HPV infection in BD cases, as it can be also detected in β-HPV infected and HPV-negative cases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014083
003      
CZ-PrNML
005      
20200720081013.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/DAD.0000000000000530 $2 doi
035    __
$a (PubMed)26913849
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Švajdler, Marián $u *Šikl's Department of Pathology, the Faculty of Medicine and Faculty Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic; †Bioptická laboratoř, s.r.o., Pilsen, Czech Republic; ‡Department of Pathology, Louis Pasteur University Hospital, Košice, Slovakia; and §Integrated Cancer Research Center, School of Biology and Parker H. Petit Institute of Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA.
245    10
$a Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients / $c M. Švajdler, R. Mezencev, J. Kašpírková, D. Kacerovská, DV. Kazakov, O. Ondič, M. Michal,
520    9_
$a An increased rate of second nonmelanoma skin cancers is found in immunocompromised patients. Epidemiological and molecular data implicate ultraviolet radiation as the major risk factor. In addition, there is increasing evidence supporting the role of human papillomavirus (HPV) in the pathogenesis of premalignant and malignant skin lesions in both immunocompetent and immunocompromised patients. In a retrospective cross-sectional study, the authors examined the expression of p16 by immunohistochemistry and the presence of mucosal (α-genus) and cutaneous/epidermodysplasia verruciformis (β-genus) HPV DNA by polymerase chain reaction in 29 biopsy specimens of extragenital/extraungual Bowen disease (BD) from 24 Eastern European white immunocompromised patients. Furthermore, the author evaluated the association between the expression of p16 protein and the presence of HPV DNA. Among 25 specimens from 21 patients evaluable by polymerase chain reaction, HPV DNA was detected in 10 (40%) BD lesions from 9 patients. Beta-HPV predominated over alpha-HPV types. Among 29 immunohistochemically evaluable BD specimens, 22 lesions (∼76%) from 20 patients were scored as p16 positive. HPV DNA-positive and HPV DNA-negative lesions displayed the same proportion of p16 positivity (80%) and no correlation was found between the HPV DNA presence and the p16 expression status. Our pilot study demonstrated that β-HPV infections predominate in BD cases diagnosed among immunocompromised patients, although high- and low-risk mucosal (alpha) HPV genotypes may be detected in a minority of cases. In contrast to anogenital HPV-associated lesions, positive p16 expression is not a reliable marker of high-risk α-HPV infection in BD cases, as it can be also detected in β-HPV infected and HPV-negative cases.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a biopsie $7 D001706
650    _2
$a Bowenova nemoc $x chemie $x imunologie $x virologie $7 D001913
650    _2
$a virová transformace buněk $7 D002472
650    _2
$a průřezové studie $7 D003430
650    _2
$a inhibitor p16 cyklin-dependentní kinasy $x analýza $7 D019941
650    _2
$a Česká republika $7 D018153
650    _2
$a DNA virů $x genetika $7 D004279
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a DNA testy na papilomavirus $7 D061809
650    _2
$a lidé $7 D006801
650    12
$a imunokompromitovaný pacient $7 D016867
650    _2
$a imunohistochemie $7 D007150
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a Papillomaviridae $x genetika $x imunologie $x patogenita $7 D027383
650    _2
$a infekce papilomavirem $x imunologie $x virologie $7 D030361
650    _2
$a pilotní projekty $7 D010865
650    _2
$a prekancerózy $x chemie $x imunologie $x virologie $7 D011230
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a nádory kůže $x chemie $x imunologie $x virologie $7 D012878
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mezencev, Roman
700    1_
$a Němcová, Jana $7 xx0233246
700    1_
$a Kacerovská, Denisa
700    1_
$a Kazakov, Dmitry V
700    1_
$a Ondič, Ondrej
700    1_
$a Michal, Michal
773    0_
$w MED00000240 $t The American Journal of dermatopathology $x 1533-0311 $g Roč. 38, č. 10 (2016), s. 751-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26913849 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20200720081013 $b ABA008
999    __
$a ok $b bmc $g 1200548 $s 974861
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 38 $c 10 $d 751-7 $i 1533-0311 $m The American journal of dermatopathology $n Am J Dermatopathol $x MED00000240
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...